自噬
GPX4
程序性细胞死亡
PI3K/AKT/mTOR通路
细胞生物学
诱导剂
癌症研究
细胞凋亡
癌症
癌细胞
生物
信号转导
氧化应激
谷胱甘肽过氧化物酶
生物化学
超氧化物歧化酶
遗传学
基因
作者
Yadong Sun,Niklas Berleth,Wenxian Wu,David Schlütermann,Jana Deitersen,Fabian Stuhldreier,Lena Berning,Annabelle Friedrich,Seda Akgün,María José Mendiburo,Sebastian Wesselborg,Marcus Conrad,Carsten Berndt,Björn Stork
标识
DOI:10.1038/s41419-021-04306-2
摘要
Abstract Ferroptosis is a form of regulated cell death that emerges to be relevant for therapy-resistant and dedifferentiating cancers. Although several lines of evidence suggest that ferroptosis is a type of autophagy-dependent cell death, the underlying molecular mechanisms remain unclear. Fin56, a type 3 ferroptosis inducer, triggers ferroptosis by promoting glutathione peroxidase 4 (GPX4) protein degradation via a not fully understood pathway. Here, we determined that Fin56 induces ferroptosis and autophagy in bladder cancer cells and that Fin56-triggered ferroptosis mechanistically depends on the autophagic machinery. Furthermore, we found that autophagy inhibition at different stages attenuates Fin56-induced oxidative stress and GPX4 degradation. Moreover, we investigated the effects of Fin56 in combination with Torin 2, a potent mTOR inhibitor used to activate autophagy, on cell viability. We found that Fin56 synergizes with Torin 2 in cytotoxicity against bladder cancer cells. Collectively, our findings not only support the concept that ferroptosis is a type of autophagy-dependent cell death but imply that the combined application of ferroptosis inducers and mTOR inhibitors is a promising approach to improve therapeutic options in the treatment of bladder cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI